<DOC>
	<DOCNO>NCT01559168</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy UpholdTM LITE mesh 12 month follow period , use composite outcome include good anatomical correction anterior apical compartment ( stage 0 1 ) , prolapse ( bulge ) symptom ( answer `` '' question 3 PFDI-20 ) reintervention recurrent prolapse anterior apical compartment .</brief_summary>
	<brief_title>Uphold Mesh Surgical Treatment Uterine-predominant Prolapse</brief_title>
	<detailed_description>Secondary objective include evaluation following : - Change baseline POP-Q score 6 week , 6 month 12 month post procedure , include evolution treat non-treated posterior compartment . - The proportion patient anatomical prolapse ( C/D ) , asymptomatic . - Change baseline mean quality-of-life score . - Evaluation mesh property procedure date study period . - Peri-operative post-treatment pain score assessment compare various anesthesia regime use ( Visual Analog Scale ) . - Assessment patient subjective outcome overall treatment effect satisfaction . - Objective evaluation mesh shrinkage standardize ultrasound measurement .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient available 12 month followup Patients symptom alter quality life relation uterine posthysterectomy vault prolapse Patients receive UpholdTM LITE mesh Kit Female patient &gt; = year desire future pregnancy Diagnosed pelvic organ prolapse &gt; = ICS POPQ Stage 2 Symptomatic Prolapse apical compartment ( uterine vault ) , associate ICS POPQ Stage 2 3 Symptomatic Prolapse anterior compartment ( point Ba &gt; = 1 Patients willing complete quality life questionnaire baseline ( preprocedure ) 6 week , 6 12 month postprocedure The patient participate another study The patient exclusion period determine previous study The patient judicial protection , tutorship curatorship The patient refuse sign consent It impossible correctly inform patient The patient pregnant , parturient , breastfeed Patients receive UpHoldTM LITE mesh Kit Patients &lt; 50 year Patients qho , accord clinical judgment investigator , suitable study Patients consider future pregnancy Patients whose pelvic organ prolapse &lt; = 1 ICS Stage Patients require Posterior Graft procedure Patients know suspected hypersensitivity polypropylene Patients pathology ould compromise implant placement Patients pathology ould compromise implant placement mention device instruction manual Patients pathology would limit blood supply compromise heal Patients blood coagulation disorder ( associate current level coagulation ) Patients autoimmune connective tissue disease Patients upper urinary tract obstruction renal insufficiency Patients local systemic infection</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>